Literature DB >> 58263

Mechanism of renal hypertension.

J J Brown, D L Davies, J J Morton, J I Robertson, V Cuesta, A F Lever, P L Padfield, P Trust.   

Abstract

Renal hypertension of the two-kidney type is divided into three stages. In the first, hypertension results from the vasoconstrictor effect of angiotensin II. This persists to some extent in the second phase but there is in addition a slow-developing pressor effect, also resulting from angiotensin II and probably attributable to sodium. In the first two phases removal of the abnormal kidney corrects the hypertension. This fails in the third phase because changes in the opposite kidney maintain hypertension. Renin and angiotensin are probably not involved at this stage.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 58263     DOI: 10.1016/s0140-6736(76)92165-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  11 in total

Review 1.  Selective alpha 1-adrenoreceptor blockers in the treatment of hypertension: should we be using them more?

Authors:  M Ligueros; R Unwin; M Wilkins
Journal:  Clin Auton Res       Date:  1991-09       Impact factor: 4.435

2.  Hydrogen sulfide inhibits plasma renin activity.

Authors:  Ming Lu; Yi-Hong Liu; Hong Swen Goh; Josh Jia Xing Wang; Qian-Chen Yong; Rui Wang; Jin-Song Bian
Journal:  J Am Soc Nephrol       Date:  2010-04-01       Impact factor: 10.121

Review 3.  An update on renovascular hypertension.

Authors:  Martin Senitko; Andrew Z Fenves
Journal:  Curr Cardiol Rep       Date:  2005-11       Impact factor: 2.931

4.  Reversal of "one kidney" to "two kidney" tipe of Goldblatt hypertension in a patient with bilateral artery stenosis.

Authors:  B Scherer; E Uhlich; P C Weber; G Heberer
Journal:  Klin Wochenschr       Date:  1977-09-15

Review 5.  Role of the sympathetic nervous system in human renovascular hypertension.

Authors:  M Johansson; P Friberg
Journal:  Curr Hypertens Rep       Date:  2000-06       Impact factor: 5.369

6.  Inhibitors of the renin-angiotensin system in experimental hypertension, with a note on the measurement of angiotensin I, II and III during infusion of converting-enzyme inhibitor.

Authors:  J J Morton; J Casals-Stenzel; A F Lever; J A Millar; A J Riegger; M Tree
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

Review 7.  Blockade of the renin-angiotensin system in hypertensive patients with atherosclerotic renal artery stenosis.

Authors:  Faical Jarraya; Menno Pruijm; Gregoire Wuerzner; Michel Burnier
Journal:  Curr Hypertens Rep       Date:  2013-10       Impact factor: 5.369

8.  The sympathetic nervous system in hypertension due to unilateral renal artery stenosis in man.

Authors:  J S Kooner; W S Peart; C J Mathias
Journal:  Clin Auton Res       Date:  1991-09       Impact factor: 4.435

9.  Captopril in renovascular hypertension: long-term use in predicting surgical outcome.

Authors:  A B Atkinson; J J Brown; A M Cumming; R Fraser; A F Lever; B J Leckie; J J Morton; J I Robertson
Journal:  Br Med J (Clin Res Ed)       Date:  1982-03-06

10.  Sympathetic renal innervation and resistant hypertension.

Authors:  Vito M Campese; Elaine Ku; Jeanie Park
Journal:  Int J Hypertens       Date:  2011-01-20       Impact factor: 2.420

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.